Past events

  1. 4 Dec 2009
    5 Dec 2009

    The Molecular Biology and Genomics Unit of JRC-IHCP, in cooperation with the Health and Consumer protection DG of the Commission, is organising an International Workshop on Harmonisation of GMO Detection and Analysis. The Workshop, as part of the 'Enlargement, International Collaboration and Capacity Building' activities of the Unit, has the purpose to contribute to capacity building for the Latin American and Carribean Countries in the area of testing for the presence/absence of genetically modified organisms.

  2. 12 Feb 2009
    16 Feb 2009

    The theme of the 2009 AAAS Meeting is "Our Planet and Its Life: Origins and Futures" recognizes that 2009 is the 200th anniversary of Charles Darwin's birth and the 150th anniversary of the publication of his book, On the Origin of Species by Means of Natural Selection. New understanding of the processes that fascinated Darwin continues to be the focus of intense research 150 years later.

  3. 1 Oct 2008
    2 Oct 2008

    Bioforum is an Expo-Conference concerning biotechnologies. This event aims at promoting the meeting between science and business through a faster innovation and the launching of new products and services. Therefore, it is not only a scientific congress but also a moment of a more and more international technological transfer of knowledge.

  4. 5 Jun 2008
    6 Jun 2008

    The 18th meeting of the EC-US Task Force on Biotechnology is hosted by the JRC Institute for Health and Consumer Protection (IHCP). The meeting has been preceded by a workshop on "Current status and potential developments of nanobiotechnology research" on 3-4 June in Ispra.

  5. 15 Oct 2007
    18 Oct 2007

    The Forum on Evidence-based Toxicology is organized by scientists active in the field of toxicology, life sciences, biostatistics, modelling and medicine and is supported by the JRC's Institute for Health and Consumer Protection (IHCP). The scope of the forum is to explore the concept of an “evidence-based toxicology”, following the successful example of “evidence-based medicine”, a movement which aims at transparent decision-making in medicine on the basis of the best evidence available. This is achieved by integrating expert knowledge with structured approaches of data reviewing, data grouping and meta analysis in basic science, method assessment and decision-making and similar approaches might be embraced by toxicology.